Warnings mark a first for FDA about OTC topicals rendered unapproved due to labeling for STI treatment and latest action to ...

Vertex Pharmaceuticals’ CDIO Agam Upadhyay outlines the firm’s three-pronged AI approach, the value realization framework keeping every deployment accountable and the CEO's seemingly impossible ask ...

European medical device market growth slowed to 1.8% in 2025 from 6.0%, and the number of medtech companies fell for the first time in the report’s history, according to MedTech Europe’s 2026 Facts & ...

A bipartisan Senate bill that would end the Trump Administration’s 340B rebate model pilot and create a national claims ...

Kevin Lobo announced plans to step down as Stryker's CEO after 14 years in the role and 15 with the company, during which the ...

HHS' attorney said professional organizations cannot challenge the ACIP member appointments because no final agency action ...

The National Institute of Allergy and Infectious Diseases also is weighing whether to participate in trials involving ...

Novo will not submit its Ozempic/Wegovy/Rybelsus franchise and AstraZeneca refused to enter its Calquence into the 340B ...

Consumer health sales are growing across the Nordics and access to non-prescription products is widening, but Conaxess ...

CNS drug development has long presented significant challenges. Diseases can be severe and chronic, diagnoses may take years, ...

The global coalition of medicines regulatory authorities, ICMRA, is pressing regulators to align acceptance of non-animal ...

The long-acting injectable was superior to daily oral therapy at viral suppression in treatment-experienced patients who had ...